Mobipro Tablet is a combination of three medicines: Glucosamine, Diacerein and Methyl Sulfonyl Methane which treat osteoarthritis. Glucosamine and Diacerein are proteoglycan synthesis stimulators while Methyl Sulfonyl Methane (MSM) is a nutritional supplement. Together, they help in the building of cartilage (the soft tissue around the joints) leading to joint repair. MSM additionally lowers inflammation (swelling) of the joints.
Interaction with alcohol is unknown. Please consult your doctor.
Unknown. Human and animal studies are not available. Please consult your doctor.
No information is available on the use of Mobipro Tablet during lactation. Please consult your doctor.
It is not known whether Mobipro Tablet alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Mobipro Tablet is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Mobipro Tablet may not be needed in these patients. Please consult your doctor.
Mobipro Tablet is probably unsafe to use in patients with liver disease and should be avoided. Please consult your doctor.
“The following are the results of on-going survey on 1mg.com for Mobipro Tablet. These results only indicate the perceptions of the website users. Please base your medical decisions only on the advice of a doctor or a registered medical professional.”
Information last updated by Dr. Varun Gupta, MD Pharmacology on 6th Sep 2018.